PNPLA3 and Hepatic fibrosis: Similarly, when using LSM, the progression of liver fibrosis was reported in 8.1%, 13.2% and 23.2% of patients with PNPLA3 CC, CG and GG genotypes, respectively, with an adjusted odds ratio of 1.90 [62].